You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDX-010

Showing 1 - 25 of 156
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)

Recruiting
  • Metastatic Non-Small Cell Lung Carcinoma
  • Pembrolizumab Injection
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 6, 2022

Precise Prediction of Therapy Efficiency Trial (biopsy of tumor before treatment)

Not yet recruiting
  • Precise Prediction of Therapy Efficiency
  • biopsy of tumor before treatment
  • (no location specified)
Jan 31, 2023

Advanced NSCLC Trial in Shanghai (GLS-012+GLS-010, GLS-012+GLS-010+pemetrexed+carboplatin,

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shang Hai Pulmonary Hospital
Aug 3, 2023

NSCLC Trial in Worldwide (Pralatrexate, Erlotinib, Vitamin B12)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Bakersfield, California
  • +46 more
Feb 8, 2021

Reconstitution ofHuman Immune System inPatient Derived Xenograft

Suspended
  • Genito Urinary Cancer
  • +3 more
  • Bone marrow biopsy
  • Tumor biopsy
  • Durham, North Carolina
    Duke University Medical Center
Nov 17, 2022

Locally Advanced Pancreatic Cancer Trial (Stereotactic body radiation(SBRT), Zimberelimab (GLS-010))

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Stereotactic body radiation(SBRT)
  • Zimberelimab (GLS-010)
  • (no location specified)
Aug 22, 2023

Malignant Tumors Trial (IMMH-010)

Enrolling by invitation
  • Malignant Neoplasms
  • Guangzhou, China
    Guangdong Provincial People's Hospital
Dec 30, 2022

Breast Cancer Female Trial in Clermont-Ferrand (blood samples collection)

Recruiting
  • Breast Cancer Female
  • blood samples collection
  • Clermont-Ferrand, Puy-de-Dôme, France
    Centre Jean PERRIN
Mar 9, 2022

Multiple Myeloma Trial in Zhengzhou, Wuhan, Xi'an (Selinexor (80mg/d), Selinexor (100mg/d), Pegylated liposomal doxorubicin)

Recruiting
  • Multiple Myeloma
  • Selinexor (80mg/d)
  • +4 more
  • Zhengzhou, Henan, China
  • +4 more
Aug 16, 2022

Solid Tumor Trial in Beijing (GLS-012, GLS-010)

Recruiting
  • Solid Tumor
  • Beijing, China
    Beijing Cancer Hospital
Jun 11, 2023

APDS Trial in Netherlands, United States (Leniolisib)

Not yet recruiting
  • APDS
  • Los Angeles, California
  • +4 more
Jan 12, 2023

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)

Not yet recruiting
  • Central Nervous System Lymphoma
  • Hefei, Anhui, China
  • +4 more
Jan 26, 2023

Persistent, Recurrent, or Metastatic Cervical Cancer Trial in Shanghai (GLS-010, Placebo, paclitaxel)

Not yet recruiting
  • Persistent, Recurrent, or Metastatic Cervical Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Hospital
Apr 4, 2023

Type 1 Diabetes Trial in Edmonton (Islet isolation using BMX-010)

Completed
  • Type 1 Diabetes
  • Islet isolation using BMX-010
  • Edmonton, Alberta, Canada
    University of Alberta
May 5, 2022

Metastatic Solid Tumor Cancer Trial in Caen, Paris, Villejuif (Dose escalation, first-in-human phase I clinical trial with an

Recruiting
  • Metastatic Solid Tumor Cancer
  • Dose escalation, first-in-human phase I clinical trial with an Expansion phase
  • Caen, France
  • +2 more
Oct 11, 2022

Stargardt Disease Trial in Miami, McAllen (Gene Therapy-vMCO-010)

Active, not recruiting
  • Stargardt Disease
  • Gene Therapy-vMCO-010
  • Miami, Florida
  • +1 more
Nov 28, 2022

Secondary Progressive Multiple Sclerosis (SPMS) Trial in Tel Aviv (SCM-010)

Not yet recruiting
  • Secondary Progressive Multiple Sclerosis (SPMS)
  • SCM-010
  • Tel Aviv, Israel
    Tel Aviv Medical Center
Oct 26, 2022

Hepatic Encephalopathy Trial in Toulouse (Polydextrose)

Not yet recruiting
  • Hepatic Encephalopathy
  • Polydextrose
  • Toulouse, France
    Toulouse University Hospital
Jan 11, 2022

Constipation, Gastrointestinal Dysfunction Trial (Polydextrose, -controlled)

Completed
  • Constipation
  • Gastrointestinal Dysfunction
  • Polydextrose
  • placebo-controlled
  • (no location specified)
Apr 1, 2022

Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in China (ATG-010 and ATG-008)

Recruiting
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • ATG-010 and ATG-008
  • Chongqing, Chongqing, China
  • +5 more
Sep 2, 2022

Idiopathic Hypersomnia, Excessive Daytime Sleepiness Trial in United States (pitolisant)

Enrolling by invitation
  • Idiopathic Hypersomnia
  • Excessive Daytime Sleepiness
  • Peoria, Arizona
  • +57 more
Nov 10, 2022

Breast Cancer, Liver Metastases Trial in Leuven

Not yet recruiting
  • Breast Cancer
  • Liver Metastases
    • Leuven, Belgium
      Sophia Leduc
    Jan 31, 2023

    Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham

    Active, not recruiting
    • Retinitis Pigmentosa
    • +6 more
    • Gene Therapy Product-vMCO-010
    • Sham Injection
    • Beverly Hills, California
    • +6 more
    Jul 13, 2022

    Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +6 more
    • CB-010
    • +2 more
    • Scottsdale, Arizona
    • +7 more
    Aug 19, 2022